Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
Clinical trial NCT05093517 · COMPLETED
Trial details
- NCT number
- NCT05093517
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-10
- Primary completion
- 2022-03-16
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.